Weight Control News & Information

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight (redOrbit)LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing.

Novel diabetes treatment Syncria (albiglutide) improves glucose control and reduces weight (News-Medical-Net)New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 ...

Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control And Reduces Weight (Medical News Today)New Phase II data presented at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing.

Lack of sleep triggers weight gain despite diet control (The Times of India)WASHINGTON: Sleep restriction causes people to gain weight even when their appetite, food cravings and food consumption decreases, according to a new study.

Plant-Based, Low-Carb Diet May Promote Weight Loss And Improve Cholesterol Levels (Medical News Today)Overweight individuals who ate a low-calorie, low-carbohydrate diet high in plant-based proteins for four weeks lost weight and experienced improvements in blood cholesterol levels and other heart disease risk factors, according to a report in the June 8 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

GSK's Syncria Improves Glucose Control, Reduces Weight (Pharmaceutical Business Review)Exenatide to treat patients with type 2 diabetes with just one dose per week. ... Symlin (pramlintide acetate) injection showed improvement in glucose control for patients with type ...

Novo Nordisk?s Diabetes Shot Helps Control Blood Sugar, Weight (Bloomberg)June 7 (Bloomberg) -- Novo Nordisk A/S?s experimental diabetes shot, liraglutide, worked better than a competing product at lowering blood sugar and triggering weight loss after two years of treatment, a company-sponsored study showed.

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control with Weight Loss Over Two Years: DURATION-1 ... (Business Wire via Yahoo! Finance)NEW ORLEANS----Amylin Pharmaceuticals, Inc. , Eli Lilly and Company , and Alkermes, Inc. today announced long-term, interim results from the DURATION-1 study that showed sustained glucose control with weight loss, as well as improvements in systolic blood pressure and triglycerides, through two years of treatment with exenatide once weekly, an investigational therapy for type 2 diabetes.

Recommendations For Diabetes Patients Include Regular Exercise, Weight Training (Medical News Today)To reduce their cardiovascular risk, people with type 2 diabetes should do at least two-and-a-half hours per week of moderate-intensity or one-and-a-half hours per week of vigorous-intensity aerobic exercises, plus some weight training, according to an American Heart Association scientific statement published in Circulation: Journal of the American Heart Association.

VIVUS' Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes (redOrbit)- Year-Long Phase 2 Diabetes Study Results Presented at ADA Annual Meeting - NEW ORLEANS, June 8 /PRNewswire-FirstCall/ -- VIVUS, Inc.